Lumenis NuEra Tight
RF body contouring · Temperature-controlled monopolar RF
The Lumenis NuEra Tight typically sells new in the $60k–$90k range in the US, with used and refurbished systems around $20k–$45k. Lumenis NuEra Tight's FDA status is under verification by our research team. Figures are market estimates verified August 6, 2026.
Last verified: August 6, 2026 · How we verify
New: $60k–$90k|Used: $20k–$45kmarket estimate, no email required
| Manufacturer | Lumenis |
|---|---|
| Company | Owner: Baring Private Equity Asia (BPEA, now part of EQT) (private equity owned, since 2019) · Distribution: direct |
| Category | Body Contouring |
| Technology | Temperature-controlled monopolar RF |
| FDA status | FDA status under verification |
| New price range | $60k–$90k |
| Used price range | $20k–$45k |
| Consumables | Not published |
| Launch year | 2019 |
| Last verified | August 6, 2026 |
Bottom line
The temperature-controlled RF play from Lumenis — a comfortable, no-consumable, no-downtime heating device whose real-time thermal feedback makes it one of the more consistent and delegate-able RF boxes on the market. Understand what you're buying: temporary tissue effects with modest labeled claims, a device Lumenis distributes but does not build, and a service that lives on packages and memberships rather than dramatic before/afters. The multi-frequency depth targeting is clever and real; the results ceiling is the same as all bulk-heating RF. With GLP-1 patients flooding in with new laxity, a defensible retention-revenue machine — just never let a rep tell you it replaces a facelift or even Ultherapy.
Overview
Multi-frequency depth targeting
How it works
The science
Monopolar RF with automatic temperature control — continuous surface thermal monitoring modulating output to hold target temp (typically 42-45C) for a set dwell time, removing operator guesswork. Differentiator: selectable frequencies (roughly 470kHz up to several MHz) shifting heating depth — higher frequencies concentrate superficially for skin/wrinkle work, lower frequencies push deeper for subcutaneous/cellulite-appearance and therapeutic heating. Labeled uses: non-invasive wrinkle treatment, temporary cellulite-appearance reduction, deep tissue heating for pain/circulation/muscle spasm. Courses of 4-8 weekly sessions with maintenance; best on mild-moderate laxity and as a skin-quality adjunct for post-weight-loss patients.
Patented tech
APC automatic power/temperature control (closed-loop thermistor feedback — genuinely valuable for reproducibility and burn safety) and multi-frequency depth-tuning ("FocalRF") — straightforward RF physics productized into presets. Neither is exotic; both make the device safer to run with junior staff.
Origin
OEM-manufactured in Italy by Bios S.r.l. and distributed under the Lumenis brand — the FDA filings are in Bios's name, which tells you the real supply chain.
FDA & regulatory status
FDA status under verification — see our FDA guide. We do not publish an indication or a clearance number for this profile until the record is confirmed against the FDA database.
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Recent industry events
How we source company dataOwnership and corporate changes at Lumenis that can affect warranty, service and parts availability.
- Sep 2021
Boston Scientific acquires Lumenis surgical unit for $1.07B
DivestitureBoston Scientific acquired the Lumenis surgical/urology business for $1.07B upfront, announced March 3, 2021 and closed September 1, 2021. The aesthetics and ophthalmology businesses were retained by Baring Private Equity Asia and operate as Lumenis Be Ltd.
Source: Boston Scientific and BPEA press releases
Treatment economics
What practices charge
$250-500 face, $350-700 larger body areas, packaged 4-6 sessions ($1,200-3,000); many practices fold it into $200-400/month memberships as the recurring "tightening" service. Painless 30-45 minute sessions stack well same-day with injectables.
Consumables & recurring cost
None beyond gel and electrode accessories — under $2k/year.
Ideal for
Best-fit practice
Medspas and wellness-leaning practices wanting a low-risk, staff-delegated heat treatment for 35-65-year-olds — especially GLP-1 weight-loss patients with new laxity and needle-refusers. Solid second-or-third device; weak solo anchor. New street pricing ~$60-90k, used well below.
Compliance
Medical director & delegation
Same as all non-ablative RF — medical director in most delegation states, aesthetician-vs-nurse operation state-by-state; the therapeutic-heating indications add a wrinkle in states classifying diathermy-style devices as medical practice.
Contraindications & screening
Pacemakers/defibrillators and electronic implants, pregnancy, metal in the field, malignancy, impaired thermal sensation. Safe across all Fitzpatrick types.
Ownership
Warranty & service
1-year standard through Lumenis, extended ~$6-10k/year; note the Lumenis aesthetics organization has changed hands and distributor-sourced devices sometimes see slower parts flow than flagship lasers. Electronically simple, low-failure unit.
Resale & used market
Thin but cheap — roughly $15-35k used — because brand awareness is low and RF alternatives are abundant. Steep depreciation from new; a bargain used buy for a practice that just wants reliable temperature-controlled RF.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo verified reviews yet — be the first. Founding reviewers get a thank-you gift card for an honest review, positive or negative. How verification works.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first full census of the US aesthetic device market — preview it free.